In-stent late loss: measured at 6 months post-procedure as determined by quantitative coronary angiography (QCA). 6 months post-procedure [clinicaltrials_resource:d377fc75bb9a670c8d39777c3b532874]
Liposomal Alendronate dose of 0.001 mg
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
In-stent late loss: measured at 6 months post-procedure as determined by quantitative coronary angiography (QCA). 6 months post-procedure [clinicaltrials_resource:d377fc75bb9a670c8d39777c3b532874]
Liposomal Alendronate dose of 0.001 mg
Bio2RDF identifier
d377fc75bb9a670c8d39777c3b532874
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d377fc75bb9a670c8d39777c3b532874
measure [clinicaltrials_vocabulary:measure]
In-stent late loss: measured a ...... ve coronary angiography (QCA).
time frame [clinicaltrials_vocabulary:time-frame]
6 months post-procedure
description
Liposomal Alendronate dose of 0.001 mg
identifier
clinicaltrials_resource:d377fc75bb9a670c8d39777c3b532874
title
In-stent late loss: measured a ...... (QCA). 6 months post-procedure
@en
type
label
In-stent late loss: measured a ...... 7fc75bb9a670c8d39777c3b532874]
@en